Pathogenomics of uropathogenic Escherichia coli

Indian Journal of Medical Microbiology

Volumn 30, Issue 2, 2012, Pages 141-149

  Agarwal, J ^a   Srivastava, S ^a   Singh, M ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Pathogenesis of urinary tract infection; urinary tract infections; uropathogenic E. coli; urovirulence factors

Indexed keywords

BACTERIAL COLONIZATION; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; COMMENSALISM; GENE TRANSFER; GENETIC ANALYSIS; IMMUNE RESPONSE; MOLECULAR EVOLUTION; NONHUMAN; PATHOGENESIS; REVIEW; RISK FACTOR; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84862563630     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.96657     Document Type: Review

References (59)

1. Foxman B. Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Dis Mon 2003;49:53-70.
2. Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol 2004;2:123-40.
3. Brzuszkiewicz E, Gottschalk G, Ron E, Hacker J, Dobrindt U. Adaptation of Pathogenic E. coli to various niches: Genome fl exibility is the key. In: de Reuse H, Bereswill S, editors. Microbial Pathogenomics. 6th ed. Basel, Karger: Genome Dyn; 2009. p. 110-25.
4. Brzuszkiewicz E, Bruggemann H, Liesegang H, Emmerth M, Olschlager T, Nagy G, et al. How to become a uropathogen: Comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc Natl Acad Sci USA 2006;103:12879-84.
5. Hagan EC, Lloyd AL, Rasko DA, Faerber GJ, Mobley HL. Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog 2010;6:e1001187.
6. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991;4:80-128.
7. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ. Intracellular bacterial biofi lm-like pods in urinary tract infections. Science 2003;301:105-7.
8. Rama G, Chhina DK, Chhina RS, Sharma S. Urinary tract infections - microbial virulence determinants and reactive oxygen species. Comp Immunol Microb 2005;28:339-49.
9. Wiles TJ, Kulesus RR, Mulvey MA. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol 2008;85:11-9.
10. Bower JM, Eto DS, Mulvey MA. Covert operations of uropathogenic Escherichia coli within the urinary tract. Traffi c 2005;6:18-31.
11. Welch RA, Burland V, Plunkett G 3rd, Redford P, Roesch P, Rasko D, et al. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci USA 2002;99:17020-4.
12. Holden N, Totsika M, Dixon L, Catherwood K, Gally DL. Regulation of P-fi mbrial phase variation frequencies in Escherichia coli CFT073. Infect Immun 2007;75:3325-34.
13. Lindberg S, Xia Y, Sonden B, Goransson M, Hacker J, Uhlin BE. Regulatory interactions among adhesin gene systems of uropathogenic Escherichia coli. Infect Immun 2007;76: 771-80.
14. Schwan WR. Flagella allow uropathogenic Escherichia coli ascension into murine kidneys. Int J Med Microbiol 2008;298:441-7.
15. Hancock V, Ferrières L, Klemm P. Biofi lm formation by asymptomatic and virulent urinary tract infectious Escherichia coli strains. FEMS Microbio Lett 2007;267:30-7.
16. Hancock V, Klemm P. Global gene expression profi ling of asymptomatic bacteriuria Escherichia coli during biofi lm growth in human urine. Infect Immun 2007;75:966-76.
17. Allsopp LP, Totsika M, Tree JJ, Ulett GC, Mabbett AN, Wells TJ, et al. UpaH is a newly identifi ed autotransporter protein that contributes to biofi lm formation and bladder colonization by uropathogenic Escherichia coli CFT073. Infect Immun 2010;78:1659-69.
18. Walters MS, Mobley HL. Identifi cation of uropathogenic Escherichia coli surface proteins by shotgun proteomics. J Microbiol Methods 2009;78:131-5.
19. Henderson JP, Crowley JR, Pinkner JS, Walker JN, Tsukayama P, Stamm WE, et al. Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLoS Pathog 2009;5:e1000305.
20. Piatti G, Mannini A, Balistreri M, Schito AM. Virulence factors in urinary Escherichia coli strains: Phylogenetic background and quinolone and fl uoroquinolone resistance. J Clin Microbiol 2008;46:480-7.
21. Lloyd AL, Rasko DA, Mobley HL. Defi ning genomic islands and uropathogen-specifi c genes in uropathogenic Escherichia coli. J Bacteriol 2007;189:3532-46.
22. Zdziarski J, Svanborg C, Wullt B, Hacker J, Dobrindt U. Molecular basis of commensalism in the urinary tract: Low virulence or virulence attenuation? Infect Immun 2008;76:695-703.
23. Avasthi TS, Kumar N, Baddam R, Hussain A, Nandanwar N, Jadhav S, et al. genome of multidrug-resistant uropathogenic escherichia coli strain NA114 from India. J Bacteriol 2011;193:14272-3.
24. Mabbett AN, Ulett GC, Watts RE, Tree JJ, Totsika M, Wood JM, et al. Virulence properties of asymptomatic bacteriuria Escherichia coli. Int J Med Microbiol 2009;299:53-63.
25. Garcia EC, Brumbaugh AR, Mobley HL. Redundancy and specifi city of Escherichia coli iron acquisition systems during urinary tract infection. Infect Immun 2011;79:1225-35.
26. Moreno E, Planells I, Prats G, Planes AM, Moreno G, Andreu A. Comparative study of Escherichia coli virulence determinants in strains causing urinary tract bacteremia versus strains causing pyelonephritis and other sources of bacteremia. Diag Microbio Infect Dis 2005;3:93-9.
27. Sobel JD, Kaye D. Urinary tract infections. In: Mandell GL, Bennett JE Dolin R editors. Principles and Practice of Infectious Diseases. Philadelphia, United States: Churchill Livingstone; 2000. p. 773-805.
28. Yamamoto S, Tsukamoto T, Terai A, Kurazono H, Takeda Y, Yoshida O. Genetic evidence supporting the fecal-perinealurethral hypothesis in cystitis caused by Escherichia coli. J Urol 1997;157:1127-9.
29. Moreno E, Andreu A, Pé Rez T, Sabaté M, Johnson JR, Prats G. Relationship between Escherichia coli strains causing urinary tract infection in women and the dominant faecal fl ora of the same hosts. Epidemiol Infect 2006;134:1015-23.
30. Stamey TA, Timothy M, Millar M, Mihara G. Recurrent urinary infections in adult women: The role of introital enterobacteria. West J Med 1971;115:1-16.
31. Cooke EM. Escherichia coli and urinary tract infections. In: Cooke EM, editor. Escherichia coli and man. London: Cox and Wyman Ltd; 1974. p. 31-46.
32. Johnson JR, Scheutz F, Ulleryd P, Kuskowski MA, O'Bryan TT, Sandberg T. Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection. J Clin Microbiol 2005;43:3895-900.
33. Min G, Stolz M, Zhou G, Liang F, Sebbel P, Stoffl er D. Localization of uroplakin Ia, the urothelial receptor for bacterial adhesin FimH, on the six inner domains of the 16 nm urothelial plaque particle. J Mol Biol 2002;317:697-706.
34. Eto DS, Tiffani AJ, Sundsbak JL, Mulvey MA. Integrinmediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog 2000;73:e100.
35. Thomas WE, Trintchina E, Forero M, Vogel V, Sokurenko EV. Bacterial adhesion to target cells enhanced by shear force. Cell 2002;109:913-23.
36. Blango MG, Mulvey MA. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother 2010;54:1855-63.
37. Justice SS, Hung C, Theriot JA, Fletcher DA, Anderson GG, Footer MJ, et al. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci USA 2004;101:1333-8.
38. Dhakal B, Kulesus R, Mulvey M. Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli. Eur J Clin Invest 2008;38:S2-11.
39. Anderson GG, Goller CC, Justice S, Hultgren SJ, Seed PC. Polysaccharide capsule and sialic acidmediated regulation promote biofi lm-like intracellular bacterial communities during cystitis. Infect Immun 2010;78:963-75.
40. Anderson GG, Dodson KW, Hooton TM, Hultgren SJ. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis. Trends Microbiol 2004;12:424-30.
41. Hooten TM. Pathogenesis of urinary tract infections: An update. J Antimicrob Chemother 2000;46:1-7.
42. Cohn E, Schaeffer A. Urinary tract infections in adults. Sci World J 2004;4:76-88.
43. Bergsten G, Wullt B, Svanborg C. Escherichia coli, fi mbriae, bacterial persistence and host response induction in the human urinary tract. Int J Med Microbiol 2005;295:487-502.
44. Creagh EM, O'Neill LA. Bacteria fi ght back against Toll-like receptors. Trends Immunol 2006;27:352-7.
45. Cirl C, Wieser A, Yadav M, Duerr S, Schubert S, Fischer H, et al. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domaincontaining proteins. Nat Med 2008;14:399-406.
46. Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ. Bad bugs and beleaguered bladders: Interplay between uropathogenic Escherichia coli and innate host defences. Proc Natl Acad Sci USA 2000;97:8829-35.
47. Svensson L, Poljakovic M, Säve S, Gilberthorpe N, Schön T, Strid S, et al. Role of fl avohemoglobin in combating nitrosative stress in uropathogenic Escherichia coli- implications for urinary tract infection. Microb Pathog 2010;49:59-66.
48. Li B, Smith P, Horvath DJ Jr, Romesberg FE, Justice SS. SOS regulatory elements are essential for UPEC pathogenesis. Microbes Infect 2010;12:662-8.
49. Sivick KE, Mobley HL. Waging war against uropathogenic Escherichia coli: Winning back the urinary tract. Infect Immun 2010;78:568-85.
50. Cusumano CK, Hung CS, Chen SL, Hultgren SJ. Virulence plasmid harbored by uropathogenic Escherichia coli functions in acute stages of pathogenesis. Infect Immun 2010;78: 1457-67.
51. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000;181:261-72.
52. Jadhav S, Hussain A, Devi S, Kumar A, Parveen S, Gandham N, et al. Virulence characteristics and genetic affi nities of multiple drug resistant uropathogenic escherichia coli from a semi urban locality in India. PLoS ONE 2011;6:e18063.
53. Chapman MR, Robinson LS, Pinkner JS, Roth R, Heuser J, Hammar M, et al. Role of Escherichia coli curli operons in directing amyloid fi ber formation. Science 2002;295:851-5.
54. Soutourina OA, Bertin PN. Regulation cascade of fl agellar expression in Gram-negative bacteria. FEMS Microbiol Rev 2003;27:505-23.
55. Hunstad DA, Justice SS, Hung CS, Lauer SR, Hultgren SJ. Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infect Immun 2005;73:3999- 4006.
56. Nicholson TF, Watts KM, Hunstad DA. OmpA of uropathogenic Escherichia coli promotes postinvasion pathogenesis of cystitis. Infect Immun 2009;77:5245-51.
57. Hagan EC, Mobley HL. Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect Immun 2007;75:3941-9.
58. Guyer DM, Radulovic S, Jones FE, Mobley HL. Sat, the secreted autotransporter toxin of uropathogenic Escherichiacoli is a vacuolating cytotoxin for bladder and kidney epithelial cells. Infect Immun 2002;70:4539-46.
59. Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 2001;69:4572-9.